BD Phoenix meropenem-vaborbactam panel

Tuesday, 10 April, 2018 | Supplied by: BD



BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.

The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.

Online: www.bd.com
Phone: 02 8875 7000
Related Products

Thermo Fisher Scientific Amplitude Solution

Thermo Fisher Scientific has introduced a highly automated, real-time PCR solution designed to...

Cayman Chemical Vitamin D ELISA Kit

Cayman Chemical's Vitamin D ELISA Kit is a competitive assay that can be used for vitamin D...

Promise Proteomics SIL proteins for LC-MS/MS

Promise Advanced Proteomics' range of SIL proteins is offered as stable isotope labelled (and...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd